X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1432) 1432
Publication (191) 191
Book / eBook (179) 179
Newspaper Article (23) 23
Patent (22) 22
Conference Proceeding (21) 21
Book Chapter (12) 12
Dissertation (4) 4
Book Review (3) 3
Paper (2) 2
Report (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (445) 445
index medicus (373) 373
female (332) 332
animals (230) 230
oncology (213) 213
male (138) 138
mice (136) 136
breast cancer (134) 134
article (119) 119
middle aged (108) 108
adult (101) 101
breast neoplasms - drug therapy (99) 99
cancer (96) 96
analysis (93) 93
history (88) 88
breast neoplasms - pathology (86) 86
cell line, tumor (82) 82
breast neoplasms - metabolism (81) 81
research (80) 80
breast neoplasms - genetics (72) 72
historia (70) 70
expression (68) 68
aged (65) 65
biochemistry & molecular biology (64) 64
trastuzumab (62) 62
cell biology (61) 61
mutation (60) 60
health aspects (56) 56
medicine, general & internal (55) 55
receptor, erbb-2 - metabolism (54) 54
research article (53) 53
signal transduction (53) 53
skin and connective tissue diseases (53) 53
tumors (53) 53
antineoplastic agents - pharmacology (52) 52
cardiac & cardiovascular systems (52) 52
medicine (50) 50
phosphorylation (50) 50
antineoplastic agents - therapeutic use (49) 49
activation (46) 46
mice, nude (46) 46
genetic aspects (45) 45
breast-cancer (44) 44
risk factors (43) 43
gene expression (42) 42
care and treatment (41) 41
cells (41) 41
proteins (41) 41
receptor, erbb-2 - genetics (41) 41
chemistry (40) 40
receptor, erbb-2 - antagonists & inhibitors (40) 40
therapy (40) 40
metastasis (39) 39
adolescent (38) 38
growth-factor receptor (38) 38
her2 (38) 38
inhibition (38) 38
treatment outcome (38) 38
growth (37) 37
multidisciplinary sciences (37) 37
signal transduction - drug effects (37) 37
tumor cells, cultured (37) 37
xenograft model antitumor assays (37) 37
neoplasms (36) 36
protein kinase inhibitors - pharmacology (35) 35
receptor, epidermal growth factor - antagonists & inhibitors (35) 35
patients (34) 34
phosphatidylinositol 3-kinases - metabolism (34) 34
resistance (34) 34
apoptosis (33) 33
infectious diseases (32) 32
prognosis (32) 32
young adult (32) 32
in-vivo (31) 31
organic chemistry (31) 31
antibodies, monoclonal, humanized (30) 30
chemotherapy (30) 30
diagnosis (30) 30
politics and government (30) 30
receptor, epidermal growth factor - metabolism (30) 30
drug resistance, neoplasm (29) 29
genetics & heredity (29) 29
kinases (29) 29
parasitology (29) 29
drug resistance (28) 28
medicine, research & experimental (28) 28
physiological aspects (28) 28
breast neoplasms - enzymology (27) 27
gene-expression (27) 27
monoclonal-antibody (27) 27
peptides (27) 27
cell lung-cancer (26) 26
medicine & public health (26) 26
prevalence (26) 26
tgf-beta (26) 26
development and progression (25) 25
gene expression regulation, neoplastic (25) 25
rats (25) 25
tyrosine kinase inhibitor (25) 25
antibodies, monoclonal - therapeutic use (24) 24
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (102) 102
UTL at Downsview - May be requested (63) 63
Collection Dvlpm't (Acquisitions) - Vendor file (14) 14
Online Resources - Online (5) 5
UofT at Mississauga - Stacks (5) 5
UofT at Scarborough - Stacks (4) 4
Music - Stacks (2) 2
Robarts - Storage (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Victoria University E.J. Pratt - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Victoria University CRRS - Library use only (1) 1
Victoria University Emmanuel College - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1302) 1302
Spanish (293) 293
Portuguese (170) 170
French (8) 8
German (3) 3
Galician (2) 2
Chinese (1) 1
Japanese (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


ONCOLOGIST, ISSN 1083-7159, 2002, Volume 7, Issue 4, pp. 31 - 39
The epidermal growth factor receptor (EGFR) is a rational target for antitumor strategies. EGFR signaling causes increased proliferation, decreased apoptosis,... 
prognostic factor | EGFR-TKI | ZD1839 (Iressa (TM)) | PROGNOSTIC VALUE | STEROID-RECEPTORS | EGFR | FACTOR-ALPHA | CELL LUNG-CANCER | BREAST-CANCER | cancer therapy | C-ERBB-2 PROTEIN | ONCOLOGY | predictive factor | ZD1839 IRESSA | TYROSINE KINASE INHIBITOR | MALIGNANT GLIOMAS | Prognostic factor | ZD1839 (Iressa™) | Predictive factor | Cancer therapy
Journal Article
Construction and Building Materials, ISSN 0950-0618, 02/2019, Volume 198, pp. 148 - 157
The rheological performance of a cement paste containing Coconut Fibres was analysed. Coconut fibres are by-products from agroindustry; they reinforce cement... 
Compressive strength | Cement composite | Coconut fibers | Aspect ratio | Rheology | COCONUT-FIBER | REINFORCED-CONCRETE | MATERIALS SCIENCE, MULTIDISCIPLINARY | COMPOSITES | STRENGTH | COIR | FILLER | RICE HUSK ASH | ENGINEERING, CIVIL | CONSTRUCTION & BUILDING TECHNOLOGY | CANE BAGASSE ASH | PORTLAND-CEMENT | Mechanical properties | Research | Analysis | Cement
Journal Article
Annual Review of Medicine, ISSN 0066-4219, 01/2016, Volume 67, p. 11
  Anticancer targeted therapies are designed to exploit a particular vulnerability in the tumor, which in most cases results from its dependence on an oncogene... 
Genes | Clinical trials | Kinases | Tumors | Cancer
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2012, Volume 109, Issue 8, pp. 2718 - 2723
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 01/2012, Volume 9, Issue 1, pp. 16 - 32
The advent of HER2-directed therapies has significantly improved the outlook for patients with HER2-positive early stage breast cancer. However, a significant... 
GROUP-STUDY I-01 | CLINICAL-TRIAL | ONCOLOGY | PHASE-I TRIAL | ACQUIRED AUTORESISTANCE | TYROSINE KINASE INHIBITOR | MONOCLONAL-ANTIBODY | PLUS ADJUVANT CHEMOTHERAPY | TRASTUZUMAB RESISTANCE | ENDOTHELIAL GROWTH-FACTOR | SMALL-MOLECULE INHIBITOR | Care and treatment | Cell receptors | Breast cancer | Diagnosis | Properties
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 7, pp. 904 - 916
Summary Background Phosphatidylinositol 3-kinase (PI3K) pathway activation is a hallmark of endocrine therapy-resistant, hormone receptor-positive breast... 
Hematology, Oncology and Palliative Medicine | HETEROGENEITY | WOMEN | PALBOCICLIB | THERAPY | EXEMESTANE | ONCOLOGY | MUTATION | RESISTANCE | COMBINATION | AROMATASE INHIBITORS | PI3K INHIBITOR | Estradiol - analogs & derivatives | Humans | Middle Aged | Aminopyridines - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Response Evaluation Criteria in Solid Tumors | Alanine Transaminase - blood | Receptors, Estrogen - analysis | Fulvestrant | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Neoplasm Metastasis | Hyperglycemia - chemically induced | DNA, Neoplasm - blood | DNA Mutational Analysis | Exanthema - chemically induced | Postmenopause | Female | Morpholines - adverse effects | Aminopyridines - administration & dosage | Drug Eruptions - etiology | Double-Blind Method | Morpholines - administration & dosage | Estradiol - administration & dosage | Survival Rate | Signal Transduction - genetics | Breast Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | Disease-Free Survival | Retreatment | Breast Neoplasms - genetics | Class I Phosphatidylinositol 3-Kinases | Aspartate Aminotransferases - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Receptor, ErbB-2 - analysis | Antimitotic agents | Medical colleges | Clinical trials | Product development | Breast cancer | Postmenopausal women | Hormones | Antineoplastic agents | Analysis
Journal Article
2003, Seminars in oncology, Volume 30, no. 1, suppl. 1., 55
Book
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2011, Volume 108, Issue 12, pp. 5021 - 5026
Journal Article